Hibiscus Blood Pressure Randomized Trial Evidence Table

Structured evidence table for Hibiscus Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Hibiscus Blood Pressure Randomized TrialConclusion HSE demonstrates the potential to help type 2 diabetic nephropathy patients by modifying renin-angiotensin-aldosterone system activity carbohydrate digestion processes and lipid metabolism which reduces diabetic complications risks.2Kiani M (2026)Comparison <i>of Hibiscus sabdariffa L.</i> extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial.
Hibiscus Blood Pressure Randomized Trialextract (HSE) as a supplemental therapy with valsartan for type 2 diabetic patients with nephropathy and its underlying biological functions were investigated in this study.2Kiani M (2026)Comparison <i>of Hibiscus sabdariffa L.</i> extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial.
Hibiscus Blood Pressure Randomized TrialMaterials and methods This clinical trial took place in Gorgan, Iran with 70 diabetic nephropathy patients who had hypertension.2Kiani M (2026)Comparison <i>of Hibiscus sabdariffa L.</i> extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial.
Hibiscus Blood Pressure Randomized TrialThis study assessed 8-week changes in Atherogenic and triglyceride-glucose indices (AIP and TyG) after the consumption of a Hibiscus-inulin (HIB-INU) beverage and tested whether baseline risk modified these effects.2Mendivil EJ (2025)Standardized Hibiscus-Inulin Shot Lowers Lipid-Glucose Indices in Adults with Overweight and Obesity: 8-Week Randomized Trial.
Hibiscus Blood Pressure Randomized TrialANCOVA adjusted for baseline, age, and sex was used to estimate between-group differences and to test for interactions by baseline risk.2Mendivil EJ (2025)Standardized Hibiscus-Inulin Shot Lowers Lipid-Glucose Indices in Adults with Overweight and Obesity: 8-Week Randomized Trial.
Hibiscus Blood Pressure Randomized TrialBackground: Few trials have evaluated liquid chromatography-mass spectrometry (LC-MS)-standardized ready-to-drink formulations, and short-term responses of composite lipid-glucose indices under controlled intake remain unquantified.2Mendivil EJ (2025)Standardized Hibiscus-Inulin Shot Lowers Lipid-Glucose Indices in Adults with Overweight and Obesity: 8-Week Randomized Trial.
topicHibiscus Blood Pressure Randomized Trial
claimConclusion HSE demonstrates the potential to help type 2 diabetic nephropathy patients by modifying renin-angiotensin-aldosterone system activity carbohydrate digestion processes and lipid metabolism which reduces diabetic complications risks.
evidence level2
citationKiani M (2026)
sourceComparison <i>of Hibiscus sabdariffa L.</i> extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial.
topicHibiscus Blood Pressure Randomized Trial
claimextract (HSE) as a supplemental therapy with valsartan for type 2 diabetic patients with nephropathy and its underlying biological functions were investigated in this study.
evidence level2
citationKiani M (2026)
sourceComparison <i>of Hibiscus sabdariffa L.</i> extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial.
topicHibiscus Blood Pressure Randomized Trial
claimMaterials and methods This clinical trial took place in Gorgan, Iran with 70 diabetic nephropathy patients who had hypertension.
evidence level2
citationKiani M (2026)
sourceComparison <i>of Hibiscus sabdariffa L.</i> extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial.
topicHibiscus Blood Pressure Randomized Trial
claimThis study assessed 8-week changes in Atherogenic and triglyceride-glucose indices (AIP and TyG) after the consumption of a Hibiscus-inulin (HIB-INU) beverage and tested whether baseline risk modified these effects.
evidence level2
citationMendivil EJ (2025)
sourceStandardized Hibiscus-Inulin Shot Lowers Lipid-Glucose Indices in Adults with Overweight and Obesity: 8-Week Randomized Trial.
topicHibiscus Blood Pressure Randomized Trial
claimANCOVA adjusted for baseline, age, and sex was used to estimate between-group differences and to test for interactions by baseline risk.
evidence level2
citationMendivil EJ (2025)
sourceStandardized Hibiscus-Inulin Shot Lowers Lipid-Glucose Indices in Adults with Overweight and Obesity: 8-Week Randomized Trial.
topicHibiscus Blood Pressure Randomized Trial
claimBackground: Few trials have evaluated liquid chromatography-mass spectrometry (LC-MS)-standardized ready-to-drink formulations, and short-term responses of composite lipid-glucose indices under controlled intake remain unquantified.
evidence level2
citationMendivil EJ (2025)
sourceStandardized Hibiscus-Inulin Shot Lowers Lipid-Glucose Indices in Adults with Overweight and Obesity: 8-Week Randomized Trial.

Source documents

  1. Comparison <i>of Hibiscus sabdariffa L.</i> extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial.
  2. Standardized Hibiscus-Inulin Shot Lowers Lipid-Glucose Indices in Adults with Overweight and Obesity: 8-Week Randomized Trial.